Access cutting-edge acinetobacter baumannii-calcoaceticus complex infection (abc) treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kansas City location
Preparing your pre-screening questions…
Access acinetobacter baumannii-calcoaceticus complex infection (abc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acinetobacter baumannii-calcoaceticus complex infection (abc) treatment provided free
Check if you qualify for this acinetobacter baumannii-calcoaceticus complex infection (abc) clinical trial in Kansas City, KS
No-Cost Study Care
Local to Kansas City
Convenient for KS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to evaluate the safety of sulbactam-durlobactam, as well as the risk of hypersensitivity reactions (including anaphylaxis) in participants with Acinetobacter baumannii-calcoaceticus complex infection. Participants will be followed for approximately 28 days in order to collect safety and reaction data.
Sponsor: Innoviva Specialty Therapeutics
Yes, this clinical trial (NCT06746883) has an active research site in Kansas City, KS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for acinetobacter baumannii-calcoaceticus complex infection (abc) treatment options in Kansas City, KS, this clinical trial (NCT06746883) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acinetobacter baumannii-calcoaceticus complex infection (abc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all acinetobacter baumannii-calcoaceticus complex infection (abc) clinical trials near you to find additional studies recruiting in your area.
See all neuroendocrine tumors clinical trials recruiting in Kansas City — not just this study.
Browse Neuroendocrine Tumors Trials in Kansas City →